PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, University of Cambridge, Cambridge, UK.\', \'Departments of Infectious Diseases & Microbiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.\', \'Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, UK.\', \'Windsor Research Unit, Fulbourn Hospital, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.\', \'Gnodde Goldman Sachs Translational Neuroscience Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.\', \'Department of Respiratory Medicine, Royal Papworth Hospital, Cambridge, UK.\', \'John V Farman Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.\', \'NIHR Cambridge Clinical Research Facility, Cambridge Clinical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.\', \'Office for Translational Research, University of Cambridge, Cambridge, UK.\', \'Research & Development Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.\', \'Medical Director\'s Office, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.\', \'NIHR Cambridge Biomedical Research Centre, Cambridge, UK.\', \'Department of Oncology, University of Cambridge, Cambridge, UK.\', \'Institute of Metabolic Science, University of Cambridge, Cambridge, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/17407745211024764
?:hasPublicationType
?:journal
  • Clinical trials (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34154428
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all